As myostatin was elevated in the gastrocnemius muscle of mice inoculated with the Yoshida AH-130 hepatoma [56], targeting the myostatin pathway seemed promising in preventing cancer cachexia. Here, MSTN is linked to hepatocellular carcinoma.